Engineering tissue-specific mRNA drugs

 Supervisor Dr Seth Cheetham

Current mRNA therapeutics and vaccines are designed for high and ubiquitously translation. However, for many mRNA drugs and gene therapies the expression of the therapeutic RNA in all cells is undesirable and translational control must be tailored to the target tissue. To engineer cell-type specific mRNA translation this project will use rational design and high-throughput in vivo screening of structured RNA elements. RNA modules that confer cell-type-specific or cancer-specific expression will be identified to incorporate in next-generation mRNA drug designs.
Top of page

What to do

  1. Review each project description and find one which matches your areas of interest.
  2. Contact the project advisor directly to discuss the project and arrange a meeting or visit to the AIBN lab.


AIBN Engagement Officer
07 334 64215

See all honours projects